GlucoTrack, Inc.
GCTK
$0.349
-$0.0089-2.49%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -75.90% |
| Gross Profit | -- | -- | -- | -- | 75.90% |
| SG&A Expenses | 48.67% | 23.14% | 3.85% | -2.32% | -4.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 119.45% | 158.24% | 89.73% | 60.29% | 28.50% |
| Operating Income | -119.45% | -158.24% | -89.73% | -60.29% | -28.50% |
| Income Before Tax | -149.75% | -157.67% | -88.81% | -60.02% | -28.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -149.75% | -157.67% | -88.81% | -60.02% | -28.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -149.75% | -157.67% | -88.81% | -60.02% | -28.32% |
| EBIT | -119.45% | -158.24% | -89.73% | -60.29% | -28.50% |
| EBITDA | -119.95% | -158.50% | -89.98% | -60.58% | -28.74% |
| EPS Basic | -55.06% | -46.31% | -33.42% | -27.15% | -18.61% |
| Normalized Basic EPS | -74.44% | -67.02% | -20.16% | -13.32% | -5.46% |
| EPS Diluted | -55.06% | -46.31% | -33.42% | -27.15% | -18.61% |
| Normalized Diluted EPS | -74.44% | -67.02% | -20.16% | -13.32% | -5.46% |
| Average Basic Shares Outstanding | 41.64% | 49.88% | 55.22% | 40.05% | 22.08% |
| Average Diluted Shares Outstanding | 41.64% | 49.88% | 55.22% | 40.05% | 22.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
